Cannabis and Bhang: The Ancient Sacred Herb and the Modern Mental Crisis

Cannabis is India’s most culturally significant and legally complex substance. From its mention in the Vedas as “Somlata” to its ubiquitous presence during the festival of Holi, it is a plant deeply woven into the spiritual and social fabric of the subcontinent. In the Indian medical landscape of 2026, cannabis exists in two worlds: the regulated world of AYUSH-licensed medical extracts and the unregulated world of high-potency street “Ganja.” While CBD (Cannabidiol) is gaining recognition in India for treating refractory epilepsy and chronic pain, the recreational use of high-THC (Tetrahydrocannabinol) cannabis is triggering a silent epidemic. In 2026, Indian psychiatric wards are seeing a significant rise in “Cannabis-Induced Psychosis” and a mysterious condition of intractable vomiting known as CHS. Understanding the difference between the traditional, moderate use of Bhang and the dangerous potential of modern, high-potency hybrids is essential for survival in the 2026 landscape.

This fiftieth and final installment provides an exhaustive analysis of Cannabis in the Indian context for 2026.

---

1. Substance Profile & Classification

• Generic Name: Cannabis Sativa / Cannabis Indica
• Active Compounds: THC (Psychoactive) and CBD (Non-psychoactive).
• Forms in India:
  • Bhang: Paste made from leaves and seeds (Legally regulated by State Excise).
  • Ganja: Dried flowering tops (Illegal under NDPS Act).
  • Charas: Concentrated resin/Hashish (Illegal under NDPS Act).
  • Vijaya Extracts: Full-spectrum medical oils (Regulated by Ministry of AYUSH).
• Indian Legal Status:
  • NDPS Act 1985: Prohibits Ganja and Charas.
  • State Excise Laws: Permit the sale of Bhang through licensed government shops in several states (e.g., UP, Rajasthan, Odisha).
  • AYUSH Regulation (2026): Permits “Vijaya” (Cannabis) based medicines for specific clinical conditions when prescribed by an Ayurvedic or Allopathic practitioner.

---

2. Market Availability and Pricing in India (May 2026)

The pricing of cannabis in India is split between the legal government Bhang shops and the premium “Wellness” extract market.

A. Licensed Bhang Shop Pricing (Excise Regulated)

In states where it is legal, Bhang is sold in “Golis” (balls) or as a loose paste.

Product Type	Unit Size	Approx. Govt. Price (INR)
Bhang Goli (Standard)	1 Goli (approx. 5g)	₹10.00 - ₹20.00
Bhang Thandai	1 Glass	₹50.00 - ₹100.00

B. Medical “Vijaya” Extracts (AYUSH Licensed)

In 2026, premium wellness brands like Vedi Herbals and Boheco offer standardized extracts.

Brand Name	Strength/Type	Unit Size	Approx. Market Price (INR)
Vijaya Full Spectrum	10% CBD / 5% THC	10ml	₹2,800.00
Cannabis Leaf Oil	1500mg CBD	30ml	₹4,500.00
CannaEase	Pain Management Oil	10ml	₹1,800.00
Ayurvedic Sleep Aid	Vijaya + Sarpagandha	30 Caps	₹1,200.00

[!IMPORTANT] The 2026 AYUSH Mandate: All cannabis-based wellness products in India must now display a QR code linking to the lab report (CoA) showing the exact levels of THC and CBD to prevent the sale of “overly potent” unregulated oils.

---

3. Clinical Pharmacology: The Endocannabinoid Master

Mechanism of Action

Cannabis works by interacting with the body’s Endocannabinoid System (ECS), which regulates sleep, appetite, and pain.

• CB1 Receptors (Brain): Primarily targeted by THC. It alters time perception, coordination, and mood.
• CB2 Receptors (Immune System): Targeted by CBD. It reduces inflammation and modulates the immune response without causing a “high.”
• The “Entourage Effect”: The theory that THC, CBD, and terpenes work better together than in isolation, which is why Indian “Vijaya” extracts are usually full-spectrum.

Pharmacokinetics

• Inhalation (Ganja/Charas): Onset in 2-5 minutes; lasts 2-4 hours.
• Oral (Bhang/Edibles): Onset in 45-90 minutes; lasts 6 to 12 hours. This is the “Bhang Trap”—users take more because they don’t feel it immediately, leading to massive overdose.

---

4. The 2026 Health Crisis: Psychosis and CHS

A. Cannabis-Induced Psychosis (CIP)

The “Ganja” of 2026 is not the mild herb of the 1970s. Modern hybrid strains have 20-30% THC.

• The Risk: In genetically predisposed individuals, high-THC cannabis can trigger a permanent psychotic break (Schizophrenia).
• Symptoms: Extreme paranoia (feeling followed), visual and auditory hallucinations, and a complete loss of reality.

B. Cannabinoid Hyperemesis Syndrome (CHS)

In 2026, Indian ERs are seeing patients with “uncontrollable vomiting” that only stops when they take a hot shower.

• The Cause: Long-term, heavy use of high-potency cannabis.
• The Cure: Total cessation of cannabis. There is no medication that can stop CHS besides quitting.

---

5. Critical Risks: The “Adulteration” Nightmare

The “Spiked” Ganja of Indian Cities

In 2026, low-quality street ganja is often “spiked” with dangerous chemicals to make it look or feel stronger:

• Rat Poison: Used to give a “shine” to the resin.
• Afeem (Opium) Water: Used to increase the weight and the addictive “nod.”
• Synthetic Cannabinoids (K2/Spice): Sprayed on poor-quality leaf to cause a violent, chemical high.

---

6. Toxicity and “The Bad Trip”

Signs of Acute Overdose (The “Green Out”)

• Severe Panic Attacks and a feeling of impending doom.
• Tachycardia (Heart rate of 140+ BPM).
• Orthostatic Hypotension (Fainting when standing up).
• Intense Nausea.

Emergency Action: Call 14446. Most “bad trips” are not fatal but require a quiet, dark room and occasionally a low-dose benzodiazepine (Part 8) to calm the heart and mind.

---

7. Addiction and Withdrawal: The “Cravings” Reality

• CUD (Cannabis Use Disorder): Approximately 9-10% of users become addicted.
• Withdrawal Symptoms: Extreme irritability, “Vivid Nightmares,” loss of appetite, and night sweats. These usually peak at Day 3 and last for 2 weeks.

Resources for Help in India

• National Drug De-addiction Helpline: 14446
• NIMHANS: Bangalore (Centre for Addiction Medicine).
• AIIMS: New Delhi (NDDTC - National Drug Dependence Treatment Centre).

---

8. Harm Reduction Strategies

• The “Wait One Hour” Rule: If consuming Bhang or edibles, never take a second dose until at least 2 hours have passed.
• The “Low-THC” Preference: If using for medical reasons, choose products with a high CBD-to-THC ratio (e.g., 2:1 or 5:1).
• Lung Protection: Vaporizing or oral consumption is significantly less damaging to the lungs than smoking “chillum” or “joints.”
• The “Adolescent” Ban: Never use cannabis before the age of 25. The brain is still developing, and early use is the #1 predictor of future psychosis.
• Avoid “Spiked” Sources: If the cannabis smells like chemicals, petrol, or has a “rubbery” texture, discard it immediately.

---

9. Regulatory Outlook 2026

The Indian government is debating a “National Medical Cannabis Policy” in late 2026, which would standardize “Vijaya” prescriptions across all states, potentially allowing medical dispensaries to operate alongside traditional Bhang shops.

---

End of the Series.

Disclaimer: This series is for educational and harm-reduction purposes only. Cannabis is a federally restricted substance in India under the NDPS Act. Its use, especially in high-potency forms, carries significant risks of mental health disorders and respiratory damage.